AbstractmWe have previously demonstrated an HLA-A*0101null allele segregating in a family with the HLA-B8, -Cw7, -DR3, -DR52, -DQ2 haplotype. In the present study the regulatory elements with known transcription enhancement activity of the silenced HLA-A*0101 allele were analyzed. In the enhancer B element, a T was substituted for a C at position -106, whereas no other alterations were found in the adjacent 59 section of the HLA-A*0101null allele. This substitution was not seen in the enhancer B elements of the corresponding genes involved in normal HLA-A*0101 membrane expression.
Comparison of enhancer B element sequences of classical functional major histocompatibility complex (MHC) class I alleles demonstrated a high degree of conservation. In contrast, many MHC class I pseudogenes showed mutation in their enhancer B boxes. These results may indicate that the single mutation detected in the enhancer B element plays a pivotal role in the abolishment of membrane expression of the HLA-A*0101null allele.
Classical human major histocompatibility complex (MHC) class I genes encode the HLA-A, -B, and -C molecules, which are expressed on virtually all nucleated cells (DavidWatine et al. 1990 ). The level of MHC class I expression varies between different tissues and cell types and even locus and allele-specific differences have been documented (Neefjes and Ploegh 1988; Hui and Soong 1992) . The regulation of MHC class I molecule expression is controlled by a number of DNA sequences located upstream of the transcription initiation site. Most of these nucleotide stretches contain recognition sites for various DNA binding proteins. The interaction between these 59 regulatory sequences and the various DNA binding proteins governs transcription activity (David-Watine et al. 1990; Halleron et al. 1986 ). Comparisons of the 59 non-coding regulatory regions of classical MHC class I genes and the rest of the multigene family reveal that considerable nucleotide sequence diversity is mainly restricted to the non-classical genes, whereas the genes that retain classical antigen presenting function display little or no polymorphism (Summers et al. 1993) . It has previously been reported that maintenance of a redundant class I locus as a functional unit is determined by conserved promoter elements that regulate responsiveness of the locus during times critical to selection. Mutations in these regulatory elements will eventually result in the extinction of the diverse array of alleles at the locus (Pease and Vallejo 1995a, b) . We have described the existence of an HLA-A*0101 allele with severely diminished transcription levels, resulting in the absence of detectable HLA-A1 expression (Lardy et al. 1992) . We postulated that the down modulated HLA-A1 expression may be due to malfunctioning cis-acting regulatory factors. In this study the 59 regulatory region of the HLA-A*0101null allele was analyzed to investigate the nature of the transcription defect.
The EBV B-cell lines with id. 25 -2120 and 25 -2160 were established from individuals in which no cell membrane expression of the HLA-A*0101 allele was detected, i.e., HLA-A1"null" (Lardy et al. 1992 ).
The EBV B-cell line with id. 25 -2230 was established from a family member with normal cell membrane expression of HLA-A1. Cell line 25 -640 was originally described as ws#9023 and was obtained from the homozygous panel cells of the Tenth International Histocompatibility Workshop (IHW).
Polymerase chain reaction (PCR) primers
The nucleotide sequences of the primers used for amplification of the 59 non-coding regulatory region of HLA class I alleles were as follows: 39A1-primer: 59TATTCTAGAGCGCCCGCGGCTCCATCT-39 (pos.+203 to +300) 59Z-primer: 59CCCGTCGACCCAGGCGTGGCTCTCAGG-39 (pos.-305 to -287) 59Y-primer: 59GTTGTCGACGACAGCTCCTGGGCCAAG-39 (pos.-395 to -377) 59X-primer: 59GGAGTCGACGATGAAAAGTGAAAGGAG-39 (pos.-457 to -440) 59W-primer: 59CTAGTCGACTCCAGGTGGACAGGTAAG-39 (pos.-574 to-556) The 39A1 primer was constructed in such a fashion that the 59 end specifically hybridizes to the HLA-A*0101 allele. The underlined nucleotide sequence denotes the restriction sites for the restriction enzymes Xba I (TCTAGA) or Sal I (GTCGAC). The nucleotide sequences of the 59 non-coding region of HLA class I alleles were obtained from Summers and co-workers 1993.
DNA cloning and sequence analysis
Genomic DNA isolation was performed according to the Eleventh International Histocompatibility Workshop (IHW) DNA component protocol (Kimura and Sasazuki 1991) . Briefly, EBV-transformed B-cell lines were lysed in a buffer containing 10 mM Tris-HCL (pH 7.6), 10 mM ethylenediaminetetraacetate (pH 8.0), and 50 mM NaCl. Genomic DNA was isolated according to the phenol-chloroform extraction procedure followed by an isopropanol precipitation step. PCR amplification of the 59 adjacent regulatory region was performed using the following primer combinations: 59W/39A1, 59X/39A1, 59Y/ 39A1, and 59Z/39A1. The PCR products were digested with Xba I/Sal I and ligated to similarly cut M13mp18/M13mp19 vectors, which were used to transform competent XL1 blue cells. Single-stranded M13mp18/mp19 DNA was isolated and nucleotide sequence of the 59 regulatory region was determined for both DNA strands by dideoxy termination using the T7 DNA polymerase sequencing system (Promega Corp., Madison, WI). Multiple clones containing the HLA-A*0101null allele were sequenced. An asterisk indicates nucleotide sequence not known or introduced to achieve the best alignment. The 59 non-coding regulatory elements are denoted above the corresponding nucleotide sequences R e s u l t s
Sequence analysis of the 59 non-coding regulatory region
We have reported an HLA-A*0101null allele which segregated in a healthy Caucasoid family (Lardy et al. 1992 ). Full-length cDNA sequence analysis did not detect any nucleotide mutations in the coding regions or altered splice sites that could account for the abrogation of the expression of this classical HLA-A*0101 allele. Due to the minute levels of HLA-A*0101 transcript, we postulated that the HLA-A*0101null allele was associated with a malfunctioning cis-acting regulatory factor. In the present study the 59 non-coding region of the HLA-A*0101null allele was analyzed. The cell lines with id. 25 -2230 and 25 -640, which expresses normal levels of HLA-A1, were used to obtain an unambiquous nucleotide consensus sequence of the 59 non-coding region of the HLA-A*0101 allele. The obtained consensus was identical to a previously published nucleotide sequence of the 59 non-coding region of the HLA-A*0101 allele (Summers et al. 1993) . Sequence analysis of the 59 regulatory region of the HLA-A*0101null allele was performed on multiple clones obtained from independent PCR amplificates of EBV B-cell lines 25 -2120 and 25 -2160. These EBV Bcell lines were derived from individuals carrying the HLA-A*0101null allele. Multiple clones were characterized that revealed a single nucleotide substitution in the enhancer B element. Extended nucleotide sequencing into exons 1 and 2 confirmed that this mutated enhancer B element indeed is linked to the HLA-A*0101null allele. Figure 1 demonstrates that in the enhancer B element at position -106, a T was substituted for a C. No further substitutions or deletions were found in any of the other regulatory sequences with known transcription enhancement activity. Furthermore, Figure 1 also demonstrates that the nucleotide sequences of the enhancer B element is highly conserved in MHC class I genes that retained their classical antigen presenting function. This is in sharp contrast to the nonfunctional MHC class I or class I-like genes with no or an undocumented function such as HLA-70, HLA-92, HLA-59, and LN11A.
Deleterious nucleotide substitutions resulting in the inactivation of a once functional gene is not a new phenomenon and has been described for several MHC loci or alleles. Examples of such events are the HLA-DQA2 locus, the I-Ea alleles in mice, the HLA-DRB4*0101102N allele, and the HLA-AR locus (Auffray et al. 1987; Begovich et al. 1990; Figueroa et al. 1990; Sutton et al. 1989; Zemmour et al. 1990 ). More recently an individual homozygous for an HLA-Anull allele, HLA-A*0215N, was reported. A single nucleotide substitution in exon 4 of the HLA-A*0207 allele resulted in the premature introduction of a stop codon. As observed in our case, this HLA-Anull gene-positive individual is healthy and exhibits no apparent immunological abnormalities (Ishikawa et al. 1995) . This is not a surprise, since the HLA system contains many MHC class I genes that have arisen from several duplication events. As a consequence, the malfunctioning of one MHC class I locus has no great effect, since the classical antigen presentation function can be replaced by another highly related locus. This study represents the analysis of the 59 non-coding region of a non-expressed classical HLA-A*0101 allele. Sequence analysis of the promoter region which is linked to the HLA-A*0101null allele revealed a single nucleotide substitution in the enhancer B element. At position -106, a T was substituted for a C. This T to C substitution was the only mutation detected in the promoter region, which might explain the abolished cell membrane expression of the HLA-A*0101null allele (Lardy et al. 1992 ).
This finding is in concordance with the findings of Balas and co-workers (1994) in which they described the presence of an HLA-A*0201 allele with highly diminished cell surface expression segregating in a healthy Spanish family. A 59-regulatory region nucleotide sequence analysis demonstrated the presence of the same unique point mutation, a T to C substitution, in the enhancer B-inverted CAT box. Although the enhancer B element has been functionally defined in the mouse (Kimura et al. 1986 ), its functional significance in the regulation of the human MHC genes has not been established. The findings reported in the present study and the study performed by Balas and co-workers (1994) do not prove but strongly suggest that the enhancer B element might play a pivotal role in the expression of MHC class I gene products. However, alternative explanations are also feasible. Assays such as site-directed mutagenesis or promoter swopping combined with gene transfection experiments are in progress. These experiments should provide more insight into the exact role of the enhancer B element in gene transcription events. J Immunol Rev 113: 27 -46, 1990 
